Wassim Kouidri, CEO of Saïdal Group, has announced the launch of a new strategic project to enhance and develop the pharmaceutical industry in the country.
In a speech delivered today, Saturday, at the Saïdal production unit in the Medea province, Kouidri explained that the new project involves “transforming raw materials from natural plants into advanced and effective pharmaceutical components.”
He added that the goal of this project is to develop the pharmaceutical industry in the country by leveraging Algeria’s substantial natural resources.
In the same context, Kouidri highlighted the significant role played by the medicine production units in Medea, noting that the Medea plant is Saïdal’s largest production unit. It has contributed not only to drug manufacturing but also to strategic projects that have advanced the pharmaceutical industry in Algeria.
For more details, visit dzwatch.dz
